New! Fundraise with Daffy Campaigns 🚀

Musculoskeletal Transplant Foundation Inc.

Musculoskeletal Transplant Foundation Inc.

Edison, NJ 088373264
Tax ID22-2803458

Want to make a donation using Daffy?

Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.

Payment method

Frequency

Amount

$USD
Daffy covers all ACH transaction fees so 100% of your donation goes to your favorite charities.

Do you work for Musculoskeletal Transplant Foundation Inc.? Learn more here.

About this organization

Revenue

$431,011,061

Expenses

$434,753,803

Website

mtf.org

Mission

MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. ("MTF- OR THE "FOUNDATION") IS DEDICATED TO PROVIDING QUALITY ALLOGRAFT TISSUE FOR TRANSPLANTATION THROUGH A COMMITMENT TO EXCELLENCE IN EDUCATION, RESEARCH, RECOVERY, AND CARE FOR RECIPIENTS, DONORS AND THEIR FAMILIES. MTF CONTINUES TO PROMOTE THE HEALTH AND WELFARE OF THE GENERAL PUBLIC BY (1) MAXIMIZING THE AVAILABILITY OF HIGH QUALITY HUMAN TISSUE INCLUDING BONE, DERMAL AND PLACENTAL TISSUE; 2) SUPPORTING MEDICAL, SCIENTIFIC AND OTHER EDUCATIONAL RESEARCH WITH RESPECT TO TISSUE DONATION, RECOVERY AND TRANSPLANTATION; (3) EDUCATING THE GENERAL PUBLIC WITH RESPECT TO THE IMPORTANCE AND BENEFITS OF TISSUE DONATION AND TRANSPLANTATION; AND (4) OTHERWISE PROMOTING TISSUE DONATION THROUGH A COMMITMENT TO EXCELLENCE IN EDUCATION, RESEARCH, RECOVERY AND CARE FOR DONORS, RECIPIENTS, AND THEIR FAMILIES. THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. WAS INCORPORATED ON JANUARY 30, 1987, AS A DISTRICT OF COLUMBIA NON-PROFIT MEMBERSHIP ORGANIZATION

About

MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. (MTF) PROVIDES ALLOGRAFT TISSUES TO THE MEDICAL COMMUNITY.SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 132,000 DONORS. IN 2018, MTF RECOVERED TISSUE FROM OVER 4,600 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 4,200 DONORS FOR USE IN BURN, GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 900 DONORS FOR USE IN WOUNDCARE APPLICATIONS AND OVER 870 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED MORE THAN 450,000 UNITS OF ALLOGRAFT TISSUE DURING 2018. IN ADDITION, MTF DONATED ALLOGRAFT TISSUES FOR RESEARCH, MEDICAL AND EDUCATIONAL PURPOSES. MTF'S RESEARCH AND DEVELOPMENT HAS CONTINUED DEVELOPMENT OF UNIQUE TISSUE FORMS FOR ORTHOPADEDIC AND GENERAL SURGICAL APPLICATIONS. MTF CONTINUES TO SEEK NEW APPLICATIONS FOR THE USE OF THE GIFT OF ALLOGRAFT TISSUES TO RESOLVE UNMET CLINICAL NEEDS AND CONTINUES TO PROVIDE SPECIAL TISSUE FOR RESEARCH PERFORMED BY MEMBERS OF THE ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE WHICH IS AN ORGANIZATION DEDICATED TO DEVELOPING MEDICAL THERAPIES AND TREATMENTS FOR WOUNDED SOLDIERS. IN 2018, MTF EXPERIENCED CONTINUED GROWTH IN THE SPORTS MEDICINE AND SPINAL ORTHOPAEDICS MARKETS, WOUND CARE AND TREMENDOUS GROWTH IN THE USE OF TISSUE FORMS IN PLASTIC AND RECONSTRUCTIVE SURGERY. HIGHLIGHTS INCLUDE THE INTRODUCTION OF CARTIMAX VIABLE CARTILAGE FIBERS; A READY TO USE, OFF THE SHELF VIABLE CARTILAGE ALLOGRAFT THAT CAN EASILY FILL LESIONS IN THE KNEE, FOOT OR ANKLE, AND FIBERFUSE AND PRIME HD DEMINERALIZED BONE FIBER BASED TISSUE PLATFORMS FOR BONE VOID FILLING APPLICATIONS. IN PLASTIC AND RECONSTRUCTIVE SURGERY, MTF EXPANDED USE OF RENUVA, AN ALLOGRAFT ADIPOSE MATRIX TO TREAT PATIENTS WITH LIPODYSTROPHY, PARRY ROMBERG SYNDROME AND CLEFT PALETTE SOFT TISSUE DEFECTS. MTF ALSO INTRODUCED LIPOGRAFTER, AN AUTOLOGOUS FAT GRAFTING SYSTEM WHICH OFFERS SURGEONS A CONVENIENT, CLOSED SYSTEM TO HARVEST AND REDISTRIBUTE FAT IN THEIR PATIENTS. IN WOUND CARE, MTF CONTINUED TO WORK ON SECURING PATIENT ACCESS THROUGH INSURANCE PROVIDERS AND THE DEVELOPMENT OF INDEPENDENT CLINCAL OUTCOME STUDIES FOR AMNIOBAND AND ALLOPATCH IN THE TREATMENT OF DIABETIC FOOT AND VENOUS LEG ULCERS. MTF CONTINUED ITS SUPPORT (SINCE 2013) OF THE AMERICAN SOCIETY OF PLASTIC SURGEONS (ASPS) AND THE PLASTIC SURGERY FOUNDATION (PSF) IN THE PURSUIT OF RESEARCH TO ADVANCE THE SCIENCE AND APPLICATION OF ALLOGENEIC TISSUE IN PLASTIC AND RECONSTRUCTIVE SURGERY. MTF ALSO CONTINUED PARTICIPATION IN BREAST RECONTRUCTION AWARENESS (BRA) DAY IN OCTOBER, A CAMPAIGN TO SUPPORT BREAST CANCER SURVIVORS' RIGHTS TO MAKE AN INFORMED DECISION WHEN CHOOSING BREAST RECONSTRUCTION OPTIONS. MTF ALSO CONTINUED ITS SUPPORT OF BIOLOGIC RESEARCH GRANTS THROUGH THE PLASTIC SURGERY FOUNDATION (PSF), FULFILLING THE ANNUAL PART OF ITS (2016) FINANCIAL PLEDGE OF 1M OVER FIVE YEARS. IN 2018 MTF FURTHER ENHANCED ITS COMPENDIUM OF CLINCAL STUDIES PROVIDING FOR EXPANDED REIMBURSEMENT COVERAGE FOR TISSUE THERAPIES IN WOUND CARE THROUGHOUT THE UNITED STATES. AMNIOBAND AND ALLOPATCH ALSO ACHIEVED ACCESS STATUS TO THE FEDERAL SUPPLY SCHEDULE (FSS) AND STRATEGIC ACQUISITION CENTER (SAC), THROUGH OUR SERVICE-DISABLED-VETERAN-OWNED SMALL BUSINESS (SDVOSB) PARTNER, ALONG WITH MTF'S BROADER ORTHOPAEDIC TISSUE PORTFOLIO, MAKING TREATMENT OPTIONS AVAILABLE TO PATIENTS WITHIN VERTERANS ADMINISTRATION FACILITIES NATIONALLY. MTF ALSO CONTINUED ITS SUPPORT OF A FIRST EVER PROSPECTIVE RANDOMIZED CLINICAL TRIAL (RCT) FOR THE USE OF ACELLULAR DERMAL MATRIX FOR BREAST RECONSTRUCTION FOLLOWING MASTECTOMY. THE USE OF HUMAN ADM FOR BREAST RECONSTRUCTION HAS BECOME THE STANDARD OF CARE FOR PLASTIC SURGEONS. IN 2017, THE FOUNDATION CONTINUED WITH ITS EFFORTS TO EXPAND ITS FOOTPRINT INTO THE WOUND CARE MARKET WITH ADVANCED WOUND CARE TISSUES. AMNIOBAND VIABLE MEMBRANE WAS LAUNCHED IN 2017 FOR THE TREATMENT OF DIABETIC AND VENOUS ULCERS. IN THE ORTHOPEDIC SPORTS TISSUE MARKET, MTF INTRODUCED A NEW TECHNOLOGY WHICH EXTENDS THE USEFUL LIFE OF FRESH OSTEOCHONDRAL ALLOGRAFTS THEREBY PROVIDING MORE TIME FOR SURGEONS TO MATCH THE GRAFT WITH RECIPIENTS. AND IN PLASTIC AND RESONSTRUCTIVE SURGERY, MTF EXPANDED ITS USE OF RENUVA, AN ALLOGAFT ADIPOSE MATRIX TO TREAT SMALL VOLUME DEFECTS ALONG WITH PROFILE PRE-SHAPED CARTILAGE SEGMENTS FOR RHINEOPLASTY PROCEDURES ELIMINATING THE NEED FOR SURGEONS TO HARVEST A RIB SEGMENT FROM THE PATIENT. FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/DONORS-FAMILIES. STORIES ABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/RECIPIENTS AND ON THE YOUTUBE CHANNEL AT HTTPS://WWW.YOUTUBE.COM/USER/THEMTF1.

Interesting data from their 2020 990 filing

The purpose of the non-profit is outlined in the filing as “Musculoskeletal transplant foundation, inc. ("mtf- or the "foundation") is dedicated to providing quality allograft tissue for transplantation through a commitment to excellence in education, research, recovery, and care for recipients, donors and their families. mtf continues to promote the health and welfare of the general public by (1) maximizing the availability of high quality human tissue including bone, dermal and placental tissue; 2) supporting medical, scientific and other educational research with respect to tissue donation, recovery and transplantation; (3) educating the general public with respect to the importance and benefits of tissue donation and transplantation; and (4) otherwise promoting tissue donation through a commitment to excellence in education, research, recovery and care for donors, recipients, and their families. the musculoskeletal transplant foundation, inc. was incorporated on january 30, 1987, as a district of columbia non-profit membership organization”.

When discussing its operations, they were defined as: “Musculoskeletal transplant foundation, inc. ("mtf- or the "foundation") is dedicated to providing quality allograft tissue for transplantation through a commitment to excellence in education, research, recovery, and care for recipients, donors and their families. mtf continues to promote the health and welfare of the general public by (1) maximizing the availability of high quality human tissue including bone, dermal and placental tissue; 2) supporting medical, scientific and other educational research with respect to tissue donation, recovery and transplantation; (3) educating the general public with respect to the importance and benefits of tissue donation and transplantation; and (4) otherwise promoting tissue donation through a commitment to excellence in education, research, recovery and care for donors, recipients, and their families. the musculoskeletal transplant foundation, inc. was incorporated on january 30, 1987, as a district of columbia non-profit membership organization”.

  • The state where the non-profit operates has been legally reported as DC.
  • The filing indicates that the non-profit's address in 2020 is located at 125 MAY ST, EDISON, NJ, 08837.
  • The non-profit has reported 1320 employees on their form as of 2020.
  • Does not operate a hospital.
  • Does not operate a school.
  • Does not collect art.
  • Does not provide credit counseling.
  • Has foreign activities.
  • Is not a donor advised fund.
  • Is not a private foundation.
  • Expenses are greater than $1,000,000.
  • Revenue is greater than $1,000,000.
  • Revenue less expenses is -$3,742,742.
  • The CEO's remuneration policy within the organization is established through an impartial review and endorsement process.
  • The organization elects its board members.
  • The organization has a written policy that describes how long it will retain documents.
  • The organization has a foreign financial account.
  • The organization has 11 independent voting members.
  • The organization was formed in 1987.
  • The organization has a written policy that addresses conflicts of interest.
  • The organization is required to file Schedule B.
  • The organization is required to file Schedule J.
  • The organization is required to file Schedule O.
  • The organization engages in lobbying activities.
  • The organization pays $116,314,464 in salary, compensation, and benefits to its employees.
  • The organization pays $0 in fundraising expenses.
  • The organization provides Form 990 to its governing body.
  • The organization has minutes of its meetings.
  • The organization has a written whistleblower policy.
  • The organization has grants to organizations.
  • The organization's financial statements were reviewed by an accountant.

Additional Non-Profits in the area

By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.